Advertisement

Acta Parasitologica

, Volume 64, Issue 3, pp 575–581 | Cite as

Identification of Host Proteins Interacting with Toxoplasma gondii SAG1 by Yeast Two-Hybrid Assay

  • Meng-Yee Lai
  • Nazia Abdul-Majid
  • Yee-Ling LauEmail author
Original Paper

Abstract

Toxoplasma gondii is one of the most successful human pathogens. To eliminate the infection, identification of receptors or binding partners from humans is indeed urgent. T. gondii surface antigen is the ultimate component involved during the attachment of parasite into host cell. However, mechanism of invasion between SAG and host-cell membrane remains unclear. Yeast two-hybrid experiment was used to identify the binding partners from cDNA human library by using T. gondii SAG1 as bait. Mated yeast cells were plated on DDO/X plates to confirm only prey plasmid that expressing interacting protein was selected. We detected 39 clones interacted with SAG1 based on a series of the selection procedures. After colony PCR, only 29 clones were positive and subsequently sent for sequencing. The yeast plasmids for true positive clones were rescued by transformation into E. coli TOP 10F′ cells. Twenty-two clones were further examined by small-scale Y2H experiment. The results indicated that a strong interaction existed between Homo sapiens lysine-rich coil-coiled and SAG1 protein, which could activate the expressions of the reporter genes in diploid yeast. Co-immunoprecipitation experiment result indicated the binding between this prey and SAG1 protein was significant (Mann–Whitney U test, Z = − 1.964, P = 0.05). H. sapiens lysine-rich coil-coiled protein was found to be interacted with SAG1. This prey protein may serve as the potential drug target in vaccination study.

Keywords

Protein–protein interaction Toxoplasma gondii Co-immunoprecipitation Saccharomyces cerevisiae Yeast two-hybrid 

Notes

Acknowledgements

We thank Professor Dr. Fong Mun Yik for technical assistance and expert comments. This work was supported by University Malaya PPP Research Grant (PG066-2016A).

References

  1. 1.
    Liu Q, Wang ZD, Huang XY, Zhu XQ (2015) Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasites Vectors 8(292):1–14.  https://doi.org/10.1186/s13071-015-0902-6 CrossRefGoogle Scholar
  2. 2.
    Beck HP, Blake D, Dardé ML, Felger I, Pedraza-Díaz S, Regidor-Cerrillo J, Gómez-Bautista M, Ortega-Mora LM, Putignani L, Shiels B, Tait A, Weir W (2009) Molecular approaches to diversity of populations of apicomplexan parasites. Int J Parasitol 39:175–189CrossRefGoogle Scholar
  3. 3.
    Shin DW, Cha DY, Hua QJ, Cha GH, Lee YH (2009) Seroprevalence of Toxoplasma gondii infection and characteristics of seropositive patients in general hospitals in Daejeon, Korea. Korean J Parasitol 47:125–130CrossRefGoogle Scholar
  4. 4.
    Xiao Y, Yin J, Jiang N, Xiang M, Hao L, Lu H, Sang H, Liu X, Xu H, Ankarklev J, Lindh J, Chen Q (2010) Seroepidemiology of human Toxoplasma gondii infection in China. BMC Infect Dis 10:4.  https://doi.org/10.1186/1471-2334-10-4 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kamani J, Mani AU, Egwu GO, Kumshe HA (2009) Seroprevalence of human infection with Toxoplasma gondii and the associated risk factors, in Maiduguri, Borno state, Nigeria. Ann Trop Med Parasitol 103:317–321CrossRefGoogle Scholar
  6. 6.
    Swai ES, Schoonman L (2009) Seroprevalence of Toxoplasma gondii infection amongst residents of Tanga district in north-east Tanzania. Tanzan J Health Res 11:205–209PubMedGoogle Scholar
  7. 7.
    Fromont EG, Riche B, Rabilloud M (2009) Toxoplasma seroprevalence in a rural population in France: detection of a household effect. BMC Infect Dis 9:76.  https://doi.org/10.1186/1471-2334-9-76 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Nissapatorn V, Noor Azmi MA, Cho SM, Fong MY, Init I, Rohela M, Anuar K, Quek KF, Latt HM (2003) Toxoplasmosis: prevalence and risk factors. J Obstet Gynaecol 23:618–624.  https://doi.org/10.1080/01443610310001604376 CrossRefPubMedGoogle Scholar
  9. 9.
    Liu K, Zhang D, Wei Q, Li G, Yu J (2006) Biological role of surface Toxoplasma gondii antigen in development of vaccine. World J Gastroenterol 12:2363–2368CrossRefGoogle Scholar
  10. 10.
    Striepen B, Zinecker CF, Damm JB, Melgers PA, Gerwig GJ, Koolen M, Vliegenthart JF, Dubremetz JF, Schwarz RT (1997) Molecular structure of the “low molecular weight antigen” of Toxoplasma gondii: a glucose alpha 1-4N-acetylgalactosamine makes free glycosyl-phosphatidylinositols highly immunogenic. J Mol Biol 266:797–813CrossRefGoogle Scholar
  11. 11.
    Fields S, Song O (1989) A novel genetic system to detect protein-protein interactions. Nature 340:245–246CrossRefGoogle Scholar
  12. 12.
    Chien C, Bartel PL, Sternglanz R, Fields S (1991) The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci USA 88:9578–9582CrossRefGoogle Scholar
  13. 13.
    Cong H, Zhang M, Zhang Q, Gong J, Cong H, Xin Q, He S (2013) Analysis of structures and epitopes of surface antigen glycoproteins expressed in bradyzoites of Toxoplasma gondii. Biomed Res Int 2013:165342.  https://doi.org/10.1155/2013/165342 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lai MY, Lau YL (2018) Measurement of binding strength between prey proteins interacting with Toxoplasma gondii SAG1 and SAG2 using isothermal titration calorimetry (ITC). Acta Parasitol 63:106–113CrossRefGoogle Scholar
  15. 15.
    West LE, Gozani O (2011) Regulation of p53 function by lysine methylation. Epigenomics 3(3):361–369CrossRefGoogle Scholar
  16. 16.
    Hakimi M, Olias P, Sibley LD (2017) Toxoplasma effectors targeting host signaling and transcription. Clin Microbiol Rev 30:615–645CrossRefGoogle Scholar
  17. 17.
    Cai YH, Chen H, Jin L, You Y, Shen JL (2013) STAT3-dependent transactivation of miRNA genes following Toxoplasma gondii infection in macrophage. Parasites Vectors 6:1–9.  https://doi.org/10.1186/1756-3305-6-356 CrossRefGoogle Scholar
  18. 18.
    Chang S, Shan X, Li X, Fan W, Zhang SQ, Zhang J, Jiang N, Ma D, Mao Z (2015) Toxoplasma gondii rhoptry protein ROP16 mediates partially SH-SY5Y cells apoptosis and cell cycle arrest by directing Ser15/37 phosphorylation of p53. Int J Biol Sci 11:1215–1225CrossRefGoogle Scholar
  19. 19.
    Franco M, Shastri AJ, Boothroyd JC (2014) Infection by Toxoplasma gondii specifically induces host c-Myc and the genes this pivotal transcription factor regulates. Eukaryot Cell 13:483–493CrossRefGoogle Scholar
  20. 20.
    Ortega-Barria E, Boothroyd JC (1999) A toxoplasma lectin-like activity specific for sulfated polysaccharides is involved in host cell infection. J Biol Chem 274:1267–1276CrossRefGoogle Scholar
  21. 21.
    Carruthers VB, Håkansson S, Giddings OK, Sibley LD (2000) Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment. Infect Immun 68:4005–4011CrossRefGoogle Scholar
  22. 22.
    Azzouz N, Kamena F, Laurino P, Kikkeri R, Mercier C, Cesbron-Delauw M, Dubremetz J, De Cola L, Seeberger PH (2013) Toxoplasma gondii secretory proteins bind to sulfated heparin structures. Glycobiology 23:106–120CrossRefGoogle Scholar

Copyright information

© Witold Stefański Institute of Parasitology, Polish Academy of Sciences 2019

Authors and Affiliations

  1. 1.Department of Parasitology, Faculty of MedicineUniversity of MalayaKuala LumpurMalaysia
  2. 2.Institute of Biological Sciences, Faculty of ScienceUniversity of MalayaKuala LumpurMalaysia

Personalised recommendations